Receptor (biochemistry)

• Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay (03 Sep 2024)
  
• The effect of cannabinoid type 2 receptor agonist on morphine tolerance (02 Sep 2024)
  
• Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs (02 Sep 2024)
  
• Mechanistic QSAR analysis to predict the binding affinity of diverse heterocycles as selective cannabinoid 2 receptor inhibitor (02 Sep 2024)
  
• Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism (02 Sep 2024)
  
• Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling (02 Sep 2024)
  
• Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists (02 Sep 2024)
  
• Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors (02 Sep 2024)
  
• Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies (02 Sep 2024)
  
• Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors (30 Aug 2024)
  
• A collection of cannabinoid-related negative findings from autaptic hippocampal neurons (30 Aug 2024)
  
• Structural basis of selective cannabinoid CB2 receptor activation (29 Aug 2024)
  
• Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability (29 Aug 2024)
  
• In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies (29 Aug 2024)
  
• Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells (29 Aug 2024)
  
• Cannabinoid and Opioid Receptor Affinity and Modulation of Cancer-Related Signaling Pathways of Machaeriols and Machaeridiols from Machaerium Pers. (29 Aug 2024)
  
• Voltage dependence of the cannabinoid CB1 receptor (27 Aug 2024)
  
• A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications (27 Aug 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• A GPCR-based yeast biosensor for biomedical, biotechnological, and point-of-use cannabinoid determination (25 Aug 2024)
  
• The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors (21 Aug 2024)
  
• Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death (21 Aug 2024)
  
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products (20 Aug 2024)
  
• Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R) (20 Aug 2024)
  
• Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases (20 Aug 2024)
  
• Cholesterol as a modulator of cannabinoid receptor CB2 signaling (20 Aug 2024)
  
• Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity (20 Aug 2024)
  
• Cannabinoids and Cannabinoid Receptors: The Story so Far (20 Aug 2024)
  
• Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox (20 Aug 2024)
  
• Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor (20 Aug 2024)
  
• Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel (20 Aug 2024)
  
• Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity (19 Aug 2024)
  
• The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity (19 Aug 2024)
  
• Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (19 Aug 2024)
  
• Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines (19 Aug 2024)
  
• Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (18 Aug 2024)
  
• Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (18 Aug 2024)
  
• Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans (18 Aug 2024)
  
• Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
  
• Cannabinoid receptor type-1: breaking the dogmas (18 Aug 2024)
  
• The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (12 Aug 2024)
  
• Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation (12 Aug 2024)
  
• Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells (27 Nov 2022)
  
• The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells (05 Sep 2022)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists (05 Sep 2022)
  
• Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells (01 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy (01 Sep 2022)
  
• Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation (01 Sep 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
  
• The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
  
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
  
• Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
  
• Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study - Journal of Cannabis Research (26 Jul 2022)
  
• Endocannabinoid Discovery Timeline (21 Jul 2022)
  
• CBD & the Psychedelic Receptor (21 Jul 2022)
  
• Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)